Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1300
+0.0100 (8.33%)
Aug 26, 2026, 10:50 AM AEST

Invex Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
975153747
Market Cap Growth
20.00%48.33%-70.00%-59.60%-21.43%-46.04%
Enterprise Value
41-2-10614
Last Close Price
0.120.090.060.050.130.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
39.3729.203.7232.74204.12-
PB Ratio
1.981.270.790.711.311.48
P/TBV Ratio
1.981.270.790.711.311.48

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
19.313.85--32.02-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Debt / Equity Ratio
-1.01-1.02-1.06-1.06-1.03-1.02
Asset Turnover
0.040.040.080.020.01-
Quick Ratio
26.7624.7914.1814.5029.3649.71
Current Ratio
26.7624.7914.1814.5029.3649.71
Return on Equity (ROE)
-16.83%-8.72%-12.20%-31.18%-13.05%-8.09%
Return on Assets (ROA)
-12.75%-7.65%-9.22%-20.43%-8.10%-5.16%
Return on Capital Employed (ROCE)
-23.80%-13.50%-37.50%-40.30%-14.20%-7.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-9.27%-7.13%-36.41%-51.56%-10.63%-4.82%
Buyback Yield / Dilution
0.29%-0.51%-0.19%-0.02%-0.03%-33.77%